Path: not-for-mail
From: PaulAubrin <paul.aubrin@invalid.org>
Newsgroups: fr.misc.actualite.covid19
Subject: =?UTF-8?Q?Re=3a_=5bSource_=3f=5d_Interactions_entre_le_vaccin_covid?= =?UTF-8?Q?_et_les_autres_vaccins_=3a_non_=c3=a9tudi=c3=a9?=
Date: Mon, 2 Oct 2023 15:57:38 +0200
Organization: A noiseless patient Spider
Lines: 14
Message-Id: <ufei8i$2vj2c$2@dont-email.me>
References: <ufehg6$2vf10$1@dont-email.me> <NdkFLWpmGrmRWFS9SzwSKw6mfZg@jntp>
Mime-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
Injection-Date: Mon, 2 Oct 2023 13:57:39 -0000 (UTC)
Injection-Info: dont-email.me; posting-host="5c0e99448d68305295b2a0f641ee0453"; logging-data="3132492"; mail-complaints-to="abuse@eternal-september.org";	posting-account="U2FsdGVkX191OZ9Stkv2kwCztDH7NT9MIL91Ya9iRzw="
User-Agent: Mozilla/5.0 (X11; Linux x86_64; rv:102.0) Gecko/20100101 Thunderbird/102.15.1
Cancel-Lock: sha1:lhUk3vQ+qB4EjPDR9uJLtNtFSZU=
Content-Language: fr
In-Reply-To: <NdkFLWpmGrmRWFS9SzwSKw6mfZg@jntp>

Le 02/10/2023 à 15:53, Eric M a écrit :
> Le 02/10/2023 à 15:44, PaulAubrin a écrit :
> 
>>      Interactions with other medicinal products or concomitant 
>> administration of COMIRNATY, COMIRNATY Original/Omicron BA.1 or 
>> COMIRNATY Original/Omicron BA.4-5 with other vaccines has not been 
>> studied.
> 
> Source ?
Pfizer soi-même.
Press Release
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron 
XBB.1.5-adapted COVID-19 Vaccine in the European Union